PLAY PODCASTS
The Yield Signal for the Markets, Micron CEO Exclusive, The Obesity Drug Makers' Rally 9/28/23

The Yield Signal for the Markets, Micron CEO Exclusive, The Obesity Drug Makers' Rally 9/28/23

Carl Quintanilla, Jim Cramer and David Faber discussed the impact of rising yields on the markets. When would it be time to get bullish? You'll want to hear Jim's answer to that question. Micron CEO Sanjay Mehrotra joined the program exclusively: A lively discussion about chip maker's Q4 results -- and the guidance that weighed on the stock. Also in focus: The 2023 rally for obesity and diabetes drug makers Novo Nordisk and Lilly -- as prescriptions for weight-loss medications surge, what to expect from Nike's after-the-bell earnings, JetBlue's revenue warning, an update on Cleveland-Cliffs' takeover bid for U.S. Steel. Squawk on the Street Disclaimer

Squawk on the Street

September 28, 202346m 37s

Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Carl Quintanilla, Jim Cramer and David Faber discussed the impact of rising yields on the markets. When would it be time to get bullish? You'll want to hear Jim's answer to that question. Micron CEO Sanjay Mehrotra joined the program exclusively: A lively discussion about chip maker's Q4 results -- and the guidance that weighed on the stock. Also in focus: The 2023 rally for obesity and diabetes drug makers Novo Nordisk and Lilly -- as prescriptions for weight-loss medications surge, what to expect from Nike's after-the-bell earnings, JetBlue's revenue warning, an update on Cleveland-Cliffs' takeover bid for U.S. Steel.

 

Squawk on the Street Disclaimer


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.